查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球放射性藥物臨床前 CRO 市場：成長、未來前景、競爭分析，2024-2032 年
市場調查報告書
商品編碼
1402951

全球放射性藥物臨床前 CRO 市場：成長、未來前景、競爭分析，2024-2032 年

Radiopharmaceutical Preclinical CRO Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

放射性藥物臨床前 CRO（合約研究組織）市場是一個充滿活力的領域，對於推進放射性藥物領域的臨床前研究至關重要。預計，由於PET 示蹤劑研究的進步、腫瘤學和神經病學研究需求的增長以及CRO 之間的戰略聯盟，放射性藥物臨床前CRO 市場在2024 年至2032 年的預測期內將以8.5% 的複合年增長率增長。治療性放射性藥物開發的挑戰凸顯了無縫轉化研究的重要性。按放射性藥物類型和治療領域進行細分可以提供對市場動態的細緻入微的了解，突顯向治療應用的轉變以及神經學研究日益增長的重要性。地理劃分突顯了全球趨勢以及亞太地區在塑造臨床前放射性藥物研究的未來方面的關鍵作用。

PET示蹤研究進展

PET（正子斷層掃描）追蹤劑研究的進展極大地激活了放射性藥物臨床前 CRO 市場。作為這一點的證據，Covance和 Charles River Laboratories 等領先的 CRO 正在積極致力於開發用於各種臨床前研究的新型 PET 示蹤劑。PET 追蹤劑提高的敏感度和準確性將使臨床前研究中的影像和分析更加精確，有助於更深入地了解疾病機制和治療反應。

對腫瘤學研究的需求不斷增長

腫瘤學研究需求的不斷增長是放射性藥物臨床前 CRO 市場的主要驅動因素。Jubilant Biosys 和 Selcia 等 CRO 也有證據顯示腫瘤學的臨床前研究正在迅速增加。腫瘤治療領域不僅將在 2024 年產生可觀的收入，而且在 2024-2032 年的預測期內將呈現出最高的複合年增長率。這證實了 CRO 在支持癌症研究的進步以及為診斷和治療目的創新放射性藥物的研發做出貢獻方面的重要作用。

人們對神經學研究的興趣日益濃厚

對神經學研究日益濃厚的興趣已成為放射性藥物臨床前 CRO 市場的另一個驅動因素。實證洞察表明，Pharmaron和WuXi AppTec等 CRO 正在積極從事神經病學的臨床前研究。由於影像技術的進步和對神經退化性疾病的更好理解，神經病學治療領域在預測期內將表現出強勁的收入和較高的預期複合年增長率。這凸顯了CRO在支持神經科學研究方面的重要作用，並為神經系統疾病診斷和治療的突破鋪平了道路。

開發治療性放射性藥物的挑戰

儘管勢頭良好，但治療性放射性藥物開發的挑戰仍然是一個重大障礙。有證據表明，將臨床前研究結果轉化為臨床上可行的治療性放射性藥物時偶爾會遇到障礙。Eurofins DiscoverX 和 Nuvisan 等 CRO 正在積極應對這些挑戰，強調需要從臨床前開發到臨床開發無縫過渡。這項障礙凸顯了合作努力和強大的轉化研究框架的重要性，以克服障礙並促進臨床前驗證的放射性藥物轉化為臨床。

按放射性藥物類型進行市場分析：PET示蹤劑佔據市場主導地位

按放射性藥物類型進行的市場細分揭示了 PET 示蹤劑、SPECT（單光子發射電腦斷層掃描）示蹤劑和治療放射性藥物的動態趨勢。到 2024 年，PET 示蹤劑將主導市場，產生最高的收入，並對整體市場份額做出重大貢獻。然而，在 2024 年至 2032 年的預測期內，治療性放射性藥物的預期複合年增長率最高。這種細分支撐了放射性藥物臨床前研究的發展，並顯著轉向治療應用。

按治療領域分析：癌症領域佔市場主導地位

按治療領域的市場細分凸顯了腫瘤學、心臟病學、神經學和其他領域在臨床前研究中的主導地位。由於癌症相關研究日益受到關注，到 2024 年，腫瘤學將擁有最高的銷售額。同時，神經病學在 2024-2032 年預測期內的預期複合年增長率最高，反映出人們對理解和解決神經系統疾病的日益關注。這種細分提供了對放射性藥物在多個治療領域的臨床前測試中的多種用途的深入了解。

北美仍處於世界領先地位

放射性藥物臨床前 CRO 市場的地理細分揭示了全球趨勢和區域差異。到 2024 年，北美地區將在收入和市場份額方面均處於領先地位，其中 Covance 和 Charles River Laboratories 等 CRO 將發揮關鍵作用。然而，由於新興經濟體更注重研發以及與全球製藥公司的合作增加等因素，預計亞太地區在預測期內將呈現最高的複合年增長率。這項變化凸顯了市場的全球性以及製定區域策略以適應多樣化研究環境的必要性。

預測期內市場競爭將加劇

競爭格局的特徵是策略聯盟和整體市場前景。截至2024年，Covance、Charles River Laboratories、Pharmaron等CRO在市場上佔據主導地位，反映了他們的綜合能力和對臨床前研究的重大貢獻。策略包括與製藥公司成立合資企業、擴大服務範圍以及投資尖端技術。從2024年到2032年，這些CRO預計將繼續其策略性舉措，適應新的市場動態，並為全球放射性藥物研究的進步做出貢獻。

本報告回答的關鍵問題

影響放射性藥物臨床前 CRO 市場成長的關鍵微觀和宏觀環境因素有哪些？

現在和預測期內，就產品領域和地區而言，主要投資領域為何？

2032 年之前的預估與市場預測

在預測期間內，哪個細分市場的複合年增長率最快？

哪個細分市場擁有較大的市場份額，為什麼？

低收入和中等收入國家是否投資放射性藥物臨床前 CRO 市場？

放射性藥物臨床前 CRO 市場最大的區域市場是哪一個？

亞太、拉丁美洲、中東/非洲等新興市場的市場趨勢與動態如何？

推動放射性藥物臨床前 CRO 市場成長的主要趨勢是什麼？

主要競爭對手有哪些，以及他們提高在全球放射性藥物臨床前 CRO 市場佔有率的策略是什麼？

目錄

第一章 前言

  • 報告內容
  • 市場細分
  • 調查方法

第二章執行摘要

第三章放射性藥物臨床前CRO市場：競爭分析

  • 主要供應商的市場地位
  • 供應商採取的策略
  • 主要產業戰略
  • 等級分析：2023 年與 2031 年

第四章放射性藥物臨床前CRO市場：宏觀分析與市場動態

  • 介紹
  • 2021-2031年全球放射性藥物臨床前CRO市場價值
  • 市場動態
    • 市場驅動力
    • 市場制約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析
  • 波特的五力模型
    • 供應商權力
    • 買方的權力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭對手之間的競爭
  • PESTEL 分析
    • 政局
    • 金融情況
    • 技術狀況
    • 法律狀況
    • 社會局勢

第五章放射性藥物臨床前 CRO 市場：依服務類型，2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2031 年
  • 市場細分
    • 安全評價
    • 生物分析測試
    • 劑量配方
    • 監管支持

第六章 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2031 年
  • 市場細分
    • 製藥公司
    • 生物技術公司
    • 學術研究機構
    • 政府機構

第 7 章 放射性藥物臨床前 CRO 市場：依放射性藥物類型，2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2031 年
  • 市場細分
    • PET示蹤劑
    • SPECT示蹤劑
    • 治療性放射性藥物

第八章放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2031 年
  • 市場細分
    • 腫瘤學
    • 心臟病學
    • 神經病學
    • 其他

第9章放射性藥物臨床前CRO市場：依組織規模，2022-2032年

  • 市場概況
  • 成長/利潤分析：2023 年與 2031 年
  • 市場細分
    • 中小型企業 (SME)
    • 大製藥公司

第十章 北美放射性藥物臨床前 CRO 市場，2022-2032

  • 市場概況
  • 放射性藥物臨床前 CRO 市場：按服務類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：以放射性藥物類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依組織規模劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：按地區劃分，2022-2032 年
    • 北美
      • 美國
      • 加拿大
      • 北美其他地區

第十一章 英國/歐盟放射性藥物臨床前 CRO 市場，2022-2032

  • 市場概況
  • 放射性藥物臨床前 CRO 市場：按服務類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：以放射性藥物類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依組織規模劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：按地區劃分，2022-2032 年
    • 英國/歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他英國/歐盟

第十二章亞太放射性藥物臨床前CRO市場，2022-2032

  • 市場概況
  • 放射性藥物臨床前 CRO 市場：按服務類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：以放射性藥物類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依組織規模劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：按地區劃分，2022-2032 年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區

第十三章拉丁美洲放射性藥物臨床前 CRO 市場，2022-2032

  • 市場概況
  • 放射性藥物臨床前 CRO 市場：按服務類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：以放射性藥物類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依組織規模劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：按地區劃分，2022-2032 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲

第14章中東與非洲放射性藥物臨床前CRO市場，2022-2032

  • 市場概況
  • 放射性藥物臨床前 CRO 市場：按服務類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依最終用途產業劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：以放射性藥物類型劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依治療領域，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：依組織規模劃分，2022-2032 年
  • 放射性藥物臨床前 CRO 市場：按地區劃分，2022-2032 年
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲

第十五章公司簡介

  • Charles River Laboratories International Inc.
  • Pharmaron Beijing Co. Ltd.
  • Bioscan Inc.
  • Invicro（Konica Minolta）
  • PerkinElmer Inc.
  • Siemens Healthineers
  • IBA Radiopharma Solutions
  • Covance Inc.（Labcorp Drug Development）
  • NorthStar Medical Radioisotopes LLC
  • PAREXEL International Corporation
  • Eckert & Ziegler
  • Jubilant Radiopharma
  • Cardinal Health Inc.
  • Curium Pharma
  • ImaginAb Inc.
  • 其他主要公司
Product Code: 140035-11-23

The radiopharmaceutical preclinical CRO (Contract Research Organization) market is a dynamic sector, integral to advancing preclinical research in the field of radiopharmaceuticals. The radiopharmaceutical preclinical CRO market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032, driven by advancements in PET tracers research, the growing demand for oncology and neurology studies, and strategic collaborations among CROs. Challenges in therapeutic radiopharmaceutical development highlight the importance of seamless translational research. The segmentation by radiopharmaceutical type and therapeutic area provides a nuanced understanding of market dynamics, emphasizing the shift towards therapeutic applications and the rising significance of neurology research. The geographic segmentation underscores global trends and the pivotal role of regions like Asia-Pacific in shaping the future of preclinical radiopharmaceutical research.

Advancements in PET Tracers Research

The radiopharmaceutical preclinical CRO market experiences a significant boost from the ongoing advancements in PET (Positron Emission Tomography) tracers research. Evidence suggests that leading CROs, such as Covance and Charles River Laboratories, have actively contributed to the development of novel PET tracers for various preclinical studies. The increased sensitivity and precision offered by PET tracers enable more accurate imaging and analysis in preclinical trials, facilitating a deeper understanding of disease mechanisms and therapeutic responses.

Growing Demand for Oncology Research

The growing demand for oncology research acts as a major driver for the radiopharmaceutical preclinical CRO market. Evidential data indicates that CROs, including Jubilant Biosys and Selcia, have witnessed a surge in preclinical studies focused on oncology. The oncology therapeutic area not only commands substantial revenue in 2024 but also exhibits the highest expected CAGR during the forecast period from 2024 to 2032. This driver underscores the pivotal role of CROs in supporting advancements in cancer research, contributing to the development of innovative radiopharmaceuticals for diagnostic and therapeutic purposes.

Rising Interest in Neurology Studies

The rising interest in neurology studies emerges as another driver for the radiopharmaceutical preclinical CRO market. Evidence-based insights reveal that CROs, such as Pharmaron and WuXi AppTec, are actively engaged in preclinical research focusing on neurology. With advancements in imaging techniques and a growing understanding of neurodegenerative disorders, the neurology therapeutic area exhibits both substantial revenue and a high expected CAGR during the forecast period. This driver highlights the crucial role of CROs in supporting neuroscience research, paving the way for potential breakthroughs in the diagnosis and treatment of neurological conditions.

Challenges in Therapeutic Radiopharmaceutical Development

Despite the positive momentum, challenges in therapeutic radiopharmaceutical development pose a notable restraint. Evidence suggests occasional hurdles in the translation of preclinical findings to clinically viable therapeutic radiopharmaceuticals. CROs, including Eurofins DiscoverX and Nuvisan, actively address these challenges, emphasizing the need for seamless transitions from preclinical to clinical development. This restraint underscores the importance of collaborative efforts and a robust translational research framework to overcome barriers and expedite the clinical translation of preclinically validated radiopharmaceuticals.

Market Analysis by Radiopharmaceutical Type: PET Tracers Dominate the Market

Market segmentation by radiopharmaceutical type reveals dynamic trends in PET tracers, SPECT (Single Photon Emission Computed Tomography) tracers, and therapeutic radiopharmaceuticals. In 2024, PET tracers dominated the market, with the highest revenue and a significant contribution to the overall market share. However, the highest expected CAGR during the forecast period from 2024 to 2032 is in therapeutic radiopharmaceuticals. This segmentation underscores the evolving landscape of radiopharmaceutical preclinical research, with a notable shift toward therapeutic applications.

Market Analysis by Therapeutic Area: Oncology Segment Dominates the Market

The market segmentation by therapeutic area highlights the prominence of oncology, cardiology, neurology, and other areas in preclinical research. In 2024, oncology commands the highest revenue, driven by the increasing focus on cancer-related studies. Simultaneously, neurology emerges with the highest expected CAGR during the forecast period from 2024 to 2032, reflecting a growing emphasis on understanding and addressing neurological disorders. This segmentation provides insights into the diverse applications of radiopharmaceuticals in preclinical studies across multiple therapeutic areas.

North America Remains the Global Leader

The geographic segmentation of the radiopharmaceutical preclinical CRO market unveils global trends and regional variances. In 2024, North America led in terms of both revenue and market share, with CROs like Covance and Charles River Laboratories playing a significant role. However, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, driven by factors such as a growing focus on research and development in emerging economies and increasing collaborations with global pharmaceutical companies. This shift highlights the global nature of the market and the need for region-specific strategies to cater to diverse research landscapes.

Market Competition to Intensify during the Forecast Period

The competitive landscape of the radiopharmaceutical preclinical CRO market is characterized by strategic collaborations and a holistic market outlook. In 2024, CROs such as Covance, Charles River Laboratories, and Pharmaron dominated the market, reflecting their comprehensive capabilities and significant contributions to preclinical research. Strategies encompass collaborative ventures with pharmaceutical companies, expansion of service offerings, and investments in cutting-edge technologies. Looking ahead to the period from 2024 to 2032, these CROs are expected to continue their strategic initiatives, adapting to emerging market dynamics and contributing to the advancement of radiopharmaceutical research on a global scale.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofRadiopharmaceutical Preclinical CRO market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Radiopharmaceutical Preclinical CRO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Service Type

    • Safety Assessment
    • Bioanalytical Testing
    • Dose Formulation
    • Regulatory Affairs Support

End-Use Industry

    • Pharmaceutical Companies
    • Biotechnology Firms
    • Academic Research Institutions
    • Government Organizations

Radiopharmaceutical Type

    • PET Tracers
    • SPECT Tracers
    • Therapeutic Radiopharmaceuticals

Therapeutic Area

    • Oncology
    • Cardiology
    • Neurology
    • Others

Organization Size

    • Small and Medium Enterprises (SMEs)
    • Large Pharmaceutical Corporations

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Radiopharmaceutical Preclinical CRO market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Radiopharmaceutical Preclinical CRO market?

Which is the largest regional market for Radiopharmaceutical Preclinical CRO market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Radiopharmaceutical Preclinical CRO market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Radiopharmaceutical Preclinical CRO market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Radiopharmaceutical Preclinical CRO Market
  • 2.2. Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 (US$ Million)
  • 2.3. Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 (US$ Million)
  • 2.4. Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 (US$ Million)
  • 2.5. Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 (US$ Million)
  • 2.6. Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 (US$ Million)
  • 2.7. Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023 (US$ Million)
  • 2.8. Attractive Investment Proposition by Geography, 2023

3. Radiopharmaceutical Preclinical CRO Market: Competitive Analysis

  • 3.1. Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Vendors
  • 3.2. Strategies Adopted by Radiopharmaceutical Preclinical CRO Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2031

4. Radiopharmaceutical Preclinical CRO Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Radiopharmaceutical Preclinical CRO Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Safety Assessment
    • 5.3.2. Bioanalytical Testing
    • 5.3.3. Dose Formulation
    • 5.3.4. Regulatory Affairs Support

6. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Pharmaceutical Companies
    • 6.3.2. Biotechnology Firms
    • 6.3.3. Academic Research Institutions
    • 6.3.4. Government Organizations

7. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. PET Tracers
    • 7.3.2. SPECT Tracers
    • 7.3.3. Therapeutic Radiopharmaceuticals

8. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Oncology
    • 8.3.2. Cardiology
    • 8.3.3. Neurology
    • 8.3.4. Others

9. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Growth & Revenue Analysis: 2023 Versus 2031
  • 9.3. Market Segmentation
    • 9.3.1. Small and Medium Enterprises (SMEs)
    • 9.3.2. Large Pharmaceutical Corporations

10. North America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 10.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 10.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 10.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 10.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 10.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 10.7.1.North America
      • 10.7.1.1. U.S.
        • 10.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 10.7.1.2. Canada
        • 10.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 10.7.1.3. Rest of North America
        • 10.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 10.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 10.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 10.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 10.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

11. UK and European Union Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 11.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 11.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 11.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 11.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 11.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 11.7.1.UK and European Union
      • 11.7.1.1. UK
        • 11.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.2. Germany
        • 11.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.3. Spain
        • 11.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.4. Italy
        • 11.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.5. France
        • 11.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 11.7.1.6. Rest of Europe
        • 11.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 11.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 11.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 11.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 11.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

12. Asia Pacific Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 12.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 12.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 12.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 12.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 12.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 12.7.1.Asia Pacific
      • 12.7.1.1. China
        • 12.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.2. Japan
        • 12.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.3. India
        • 12.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.4. Australia
        • 12.7.1.4.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.4.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.4.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.4.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.4.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.5. South Korea
        • 12.7.1.5.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.5.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.5.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.5.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.5.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 12.7.1.6. Rest of Asia Pacific
        • 12.7.1.6.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 12.7.1.6.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 12.7.1.6.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 12.7.1.6.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 12.7.1.6.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

13. Latin America Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 13.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 13.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 13.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 13.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 13.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 13.7.1.Latin America
      • 13.7.1.1. Brazil
        • 13.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 13.7.1.2. Mexico
        • 13.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 13.7.1.3. Rest of Latin America
        • 13.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 13.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 13.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 13.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 13.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

14. Middle East and Africa Radiopharmaceutical Preclinical CRO Market, 2022-2032, USD (Million)

  • 14.1. Market Overview
  • 14.2. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
  • 14.3. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
  • 14.4. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • 14.5. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
  • 14.6. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
  • 14.7.Radiopharmaceutical Preclinical CRO Market: By Region, 2022-2032, USD (Million)
    • 14.7.1.Middle East and Africa
      • 14.7.1.1. GCC
        • 14.7.1.1.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.1.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.1.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.1.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.1.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 14.7.1.2. Africa
        • 14.7.1.2.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.2.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.2.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.2.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.2.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)
      • 14.7.1.3. Rest of Middle East and Africa
        • 14.7.1.3.1. Radiopharmaceutical Preclinical CRO Market: By Service Type, 2022-2032, USD (Million)
        • 14.7.1.3.2. Radiopharmaceutical Preclinical CRO Market: By End-Use Industry, 2022-2032, USD (Million)
        • 14.7.1.3.3. Radiopharmaceutical Preclinical CRO Market: By Radiopharmaceutical Type, 2022-2032, USD (Million)
        • 14.7.1.3.4. Radiopharmaceutical Preclinical CRO Market: By Therapeutic Area, 2022-2032, USD (Million)
        • 14.7.1.3.5. Radiopharmaceutical Preclinical CRO Market: By Organization Size, 2022-2032, USD (Million)

15. Company Profile

  • 15.1. Charles River Laboratories International, Inc.
    • 15.1.1. Company Overview
    • 15.1.2. Financial Performance
    • 15.1.3. Product Portfolio
    • 15.1.4. Strategic Initiatives
  • 15.2. Pharmaron Beijing Co., Ltd.
    • 15.2.1. Company Overview
    • 15.2.2. Financial Performance
    • 15.2.3. Product Portfolio
    • 15.2.4. Strategic Initiatives
  • 15.3. Bioscan, Inc.
    • 15.3.1. Company Overview
    • 15.3.2. Financial Performance
    • 15.3.3. Product Portfolio
    • 15.3.4. Strategic Initiatives
  • 15.4. Invicro (Konica Minolta)
    • 15.4.1. Company Overview
    • 15.4.2. Financial Performance
    • 15.4.3. Product Portfolio
    • 15.4.4. Strategic Initiatives
  • 15.5. PerkinElmer, Inc.
    • 15.5.1. Company Overview
    • 15.5.2. Financial Performance
    • 15.5.3. Product Portfolio
    • 15.5.4. Strategic Initiatives
  • 15.6. Siemens Healthineers
    • 15.6.1. Company Overview
    • 15.6.2. Financial Performance
    • 15.6.3. Product Portfolio
    • 15.6.4. Strategic Initiatives
  • 15.7. IBA Radiopharma Solutions
    • 15.7.1. Company Overview
    • 15.7.2. Financial Performance
    • 15.7.3. Product Portfolio
    • 15.7.4. Strategic Initiatives
  • 15.8. Covance, Inc. (Labcorp Drug Development)
    • 15.8.1. Company Overview
    • 15.8.2. Financial Performance
    • 15.8.3. Product Portfolio
    • 15.8.4. Strategic Initiatives
  • 15.9. NorthStar Medical Radioisotopes, LLC
    • 15.9.1. Company Overview
    • 15.9.2. Financial Performance
    • 15.9.3. Product Portfolio
    • 15.9.4. Strategic Initiatives
  • 15.10. PAREXEL International Corporation
    • 15.10.1. Company Overview
    • 15.10.2. Financial Performance
    • 15.10.3. Product Portfolio
    • 15.10.4. Strategic Initiatives
  • 15.11. Eckert & Ziegler
    • 15.11.1. Company Overview
    • 15.11.2. Financial Performance
    • 15.11.3. Product Portfolio
    • 15.11.4. Strategic Initiatives
  • 15.12. Jubilant Radiopharma
    • 15.12.1. Company Overview
    • 15.12.2. Financial Performance
    • 15.12.3. Product Portfolio
    • 15.12.4. Strategic Initiatives
  • 15.13. Cardinal Health, Inc.
    • 15.13.1. Company Overview
    • 15.13.2. Financial Performance
    • 15.13.3. Product Portfolio
    • 15.13.4. Strategic Initiatives
  • 15.14. Curium Pharma
    • 15.14.1. Company Overview
    • 15.14.2. Financial Performance
    • 15.14.3. Product Portfolio
    • 15.14.4. Strategic Initiatives
  • 15.15. ImaginAb, Inc.
    • 15.15.1. Company Overview
    • 15.15.2. Financial Performance
    • 15.15.3. Product Portfolio
    • 15.15.4. Strategic Initiatives
  • 15.16. Other Notable Players
    • 15.16.1. Company Overview
    • 15.16.2. Financial Performance
    • 15.16.3. Product Portfolio
    • 15.16.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 2 Global Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 3 Global Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 4 Global Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 5 Global Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 6 North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 7 North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 8 North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 9 North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 10 North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 11 U.S. Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 12 U.S. Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 13 U.S. Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 14 U.S. Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 15 U.S. Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 16 Canada Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 17 Canada Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 18 Canada Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 19 Canada Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 20 Canada Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 21 Rest of North America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 22 Rest of North America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 23 Rest of North America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 24 Rest of North America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 25 Rest of North America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 26 UK and European Union Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 27 UK and European Union Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 28 UK and European Union Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 29 UK and European Union Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 30 UK and European Union Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 31 UK Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 32 UK Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 33 UK Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 34 UK Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 35 UK Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 36 Germany Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 37 Germany Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 38 Germany Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 39 Germany Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 40 Germany Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 41 Spain Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 42 Spain Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 43 Spain Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 44 Spain Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 45 Spain Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 46 Italy Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 47 Italy Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 48 Italy Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 49 Italy Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 50 Italy Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 51 France Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 52 France Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 53 France Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 54 France Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 55 France Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 56 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 57 Rest of Europe Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 58 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 59 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 60 Rest of Europe Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 61 Asia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 62 Asia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 63 Asia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 64 Asia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 65 Asia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 66 China Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 67 China Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 68 China Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 69 China Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 70 China Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 71 Japan Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 72 Japan Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 73 Japan Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 74 Japan Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 75 Japan Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 76 India Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 77 India Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 78 India Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 79 India Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 80 India Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 81 Australia Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 82 Australia Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 83 Australia Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 84 Australia Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 85 Australia Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 86 South Korea Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 87 South Korea Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 88 South Korea Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 89 South Korea Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 90 South Korea Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 91 Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 92 Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 93 Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 94 Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 95 Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 96 Brazil Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 97 Brazil Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 98 Brazil Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 99 Brazil Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 100 Brazil Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 101 Mexico Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 102 Mexico Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 103 Mexico Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 104 Mexico Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 105 Mexico Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 106 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 107 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 108 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 109 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 110 Rest of Latin America Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 111 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 112 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 113 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 114 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 115 Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 116 GCC Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 117 GCC Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 118 GCC Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 119 GCC Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 120 GCC Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 121 Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 122 Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 123 Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 124 Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 125 Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)
  • TABLE 126 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Service Type, 2022-2032, USD (Million)
  • TABLE 127 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By End-Use Industry, 2022-2032, USD (Million)
  • TABLE 128 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Radiopharmaceutical Type, 2022-2032, USD (Million)
  • TABLE 129 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Therapeutic Area, 2022-2032, USD (Million)
  • TABLE 130 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market By Organization Size, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Radiopharmaceutical Preclinical CRO Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Radiopharmaceutical Preclinical CRO Market: Quality Assurance
  • FIG. 5 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023
  • FIG. 6 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023
  • FIG. 7 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023
  • FIG. 8 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023
  • FIG. 9 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023
  • FIG. 10 Global Radiopharmaceutical Preclinical CRO Market, By Geography, 2023
  • FIG. 11 Market Geographical Opportunity Matrix - Global Radiopharmaceutical Preclinical CRO Market, 2023

FIG. 12Market Positioning of Key Radiopharmaceutical Preclinical CRO Market Players, 2023

FIG. 13Global Radiopharmaceutical Preclinical CRO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2031

  • FIG. 14 Global Radiopharmaceutical Preclinical CRO Market, By Service Type, 2023 Vs 2032, %
  • FIG. 15 Global Radiopharmaceutical Preclinical CRO Market, By End-Use Industry, 2023 Vs 2032, %
  • FIG. 16 Global Radiopharmaceutical Preclinical CRO Market, By Radiopharmaceutical Type, 2023 Vs 2032, %
  • FIG. 17 Global Radiopharmaceutical Preclinical CRO Market, By Therapeutic Area, 2023 Vs 2032, %
  • FIG. 18 Global Radiopharmaceutical Preclinical CRO Market, By Organization Size, 2023 Vs 2032, %
  • FIG. 19 U.S. Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 20 Canada Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 21 Rest of North America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 22 UK Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 23 Germany Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 24 Spain Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 25 Italy Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 26 France Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 27 Rest of Europe Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 28 China Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 29 Japan Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 30 India Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 31 Australia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 32 South Korea Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 33 Rest of Asia Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 34 Brazil Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 35 Mexico Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 36 Rest of Latin America Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 37 GCC Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 38 Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032
  • FIG. 39 Rest of Middle East and Africa Radiopharmaceutical Preclinical CRO Market (US$ Million), 2022 - 2032